Showing results (711-720 of 812) with videos related to

Sort By:
Pageof 82
Epilepsy & Behavior : E&B|March 18, 2020
Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluationJ Adewusi, C Burness, S Ellawela, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|July 26, 2023
Mutagenesis enhances gellan gum production by a novel Sphingomonas spp.: upstream optimization, kinetic modeling, and structural and physico-functional evaluationManoj J Dev, Girish B Mahajan, Rahul G Warke, et al.
Bone Marrow Transplantation|January 10, 2001
Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosisS Singhal, A Safdar, K Y Chiang, et al.
The New England Journal of Medicine|November 24, 1999
Antitumor activity of thalidomide in refractory multiple myelomaS Singhal, J Mehta, R Desikan, et al.
Transplantation|June 27, 2000
Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patientsS Singhal, J C Shaw, J Ainsworth, et al.
Seminars in Hematology|October 1, 1996
Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemiaJ Mehta, R Powles, S Singhal, et al.
Annals of Human Genetics|June 8, 2004
Molecular analysis of GAA repeats and four linked bi-allelic markers in and around the frataxin gene in patients and normal populations from IndiaB Chattopadhyay, S Gupta, P K Gangopadhyay, et al.
Biochemical Pharmacology|August 19, 2024
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potentialPankaj Garg, Sravani K Ramisetty, Ayalur Raghu Subbalakshmi, et al.
Neurology|May 1, 1988
Prevalence of multiple sclerosis in the Parsis of BombayN E Bharucha, E P Bharucha, N H Wadia, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patientsB Sirohi, R Powles, J Mehta, et al.
Pageof 82